The Therapeutic Efficacy and Safety of Intravenous Immunoglobulin in Dermatomyositis and Polymyositis: A Systematic Review and Meta-Analysis.
Anji XiongYiying QiangYuzi CaoYu ShuaiHuini ChenQilang XiangZiyi HuZhuoyao SongShifeng ZhouYan ZhangHongxu CuiYe WangJie LuoShiquan ShuaiYuan YangPublished in: Modern rheumatology (2022)
IVIG seems to be an effective drug for DM\PM, improving muscle strength, CK levels and esophageal involvement, and it is well tolerated by patients.
Keyphrases
- end stage renal disease
- interstitial lung disease
- newly diagnosed
- peritoneal dialysis
- air pollution
- prognostic factors
- high dose
- rheumatoid arthritis
- systemic sclerosis
- type diabetes
- heavy metals
- disease activity
- emergency department
- risk assessment
- systemic lupus erythematosus
- metabolic syndrome
- weight loss
- insulin resistance
- idiopathic pulmonary fibrosis